← Grants
0

HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)

active

National Institutes of Health

917 days left

View on Grants.gov ↗

Why this scored 0

NIH pain therapeutics drug development; pharmaceutical research, not PCC2K services.

Overview

RFA-NS-27-007 · synopsis · CFDA 93.395, 93.866, 93.839, 93.867, 93.838, 93.846, 93.840, 93.213, 93.273, 93.853, 93.837, 93.233, 93.279, 93.865

Client matchesAI suggests · you decide

No client matches yet. Run matching to see which of PCC2K's clients could apply for this grant.